Skip to main content
Top

Open Access 06-09-2024 | Post-COVID Syndrome | Review

Towards an understanding of physical activity-induced post-exertional malaise: Insights into microvascular alterations and immunometabolic interactions in post-COVID condition and myalgic encephalomyelitis/chronic fatigue syndrome

Authors: Simon Haunhorst, Diana Dudziak, Carmen Scheibenbogen, Martina Seifert, Franziska Sotzny, Carsten Finke, Uta Behrends, Konrad Aden, Stefan Schreiber, Dirk Brockmann, Paul Burggraf, Wilhelm Bloch, Claudia Ellert, Anuradha Ramoji, Juergen Popp, Philipp Reuken, Martin Walter, Andreas Stallmach, Christian Puta

Published in: Infection

Login to get access

Abstract

Background

A considerable number of patients who contracted SARS-CoV-2 are affected by persistent multi-systemic symptoms, referred to as Post-COVID Condition (PCC). Post-exertional malaise (PEM) has been recognized as one of the most frequent manifestations of PCC and is a diagnostic criterion of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Yet, its underlying pathomechanisms remain poorly elucidated.

Purpose and methods

In this review, we describe current evidence indicating that key pathophysiological features of PCC and ME/CFS are involved in physical activity-induced PEM.

Results

Upon physical activity, affected patients exhibit a reduced systemic oxygen extraction and oxidative phosphorylation capacity. Accumulating evidence suggests that these are mediated by dysfunctions in mitochondrial capacities and microcirculation that are maintained by latent immune activation, conjointly impairing peripheral bioenergetics. Aggravating deficits in tissue perfusion and oxygen utilization during activities cause exertional intolerance that are frequently accompanied by tachycardia, dyspnea, early cessation of activity and elicit downstream metabolic effects. The accumulation of molecules such as lactate, reactive oxygen species or prostaglandins might trigger local and systemic immune activation. Subsequent intensification of bioenergetic inflexibilities, muscular ionic disturbances and modulation of central nervous system functions can lead to an exacerbation of existing pathologies and symptoms.
Literature
1.
go back to reference Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of Post COVID-19 condition or long COVID: a meta-analysis and systematic review. J Infect Dis. 2022;6:100122. Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of Post COVID-19 condition or long COVID: a meta-analysis and systematic review. J Infect Dis. 2022;6:100122.
2.
go back to reference Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV, Condition WCCDWG on P-C-19. A clinical case definition of post-COVID-19 condition by a delphi consensus. Lancet Infect Dis. 2021;S1473–3099:00703–9. Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV, Condition WCCDWG on P-C-19. A clinical case definition of post-COVID-19 condition by a delphi consensus. Lancet Infect Dis. 2021;S1473–3099:00703–9.
3.
go back to reference Adjaye-Gbewonyo D, Vahratian A, Perrine CG, Bertolli J. Long COVID in Adults: United States, 2022. NCHS Data Briefs No 480. 2023. Adjaye-Gbewonyo D, Vahratian A, Perrine CG, Bertolli J. Long COVID in Adults: United States, 2022. NCHS Data Briefs No 480. 2023.
4.
go back to reference Appel KS, Nürnberger C, Bahmer T, Förster C, Polidori MC, Kohls M, et al. Definition of the Post-COVID syndrome using a symptom-based Post-COVID score in a prospective, multi-center, cross-sectoral cohort of the German National Pandemic Cohort Network (NAPKON). Infection. 2024;1–17. Appel KS, Nürnberger C, Bahmer T, Förster C, Polidori MC, Kohls M, et al. Definition of the Post-COVID syndrome using a symptom-based Post-COVID score in a prospective, multi-center, cross-sectoral cohort of the German National Pandemic Cohort Network (NAPKON). Infection. 2024;1–17.
5.
go back to reference Fernández-de-las-Peñas C, Palacios-Ceña D, Gómez-Mayordomo V, Florencio LL, Cuadrado ML, Plaza-Manzano G, et al. Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: a systematic review and meta-analysis. Eur J Intern Med. 2021;92:55–70.PubMedPubMedCentralCrossRef Fernández-de-las-Peñas C, Palacios-Ceña D, Gómez-Mayordomo V, Florencio LL, Cuadrado ML, Plaza-Manzano G, et al. Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: a systematic review and meta-analysis. Eur J Intern Med. 2021;92:55–70.PubMedPubMedCentralCrossRef
6.
go back to reference Ma Y, Deng J, Liu Q, Du M, Liu M, Liu J. Long-term consequences of asymptomatic SARS-CoV-2 infection: a systematic review and meta-analysis. Int J Environ Res Public Heal. 2023;20:1613.CrossRef Ma Y, Deng J, Liu Q, Du M, Liu M, Liu J. Long-term consequences of asymptomatic SARS-CoV-2 infection: a systematic review and meta-analysis. Int J Environ Res Public Heal. 2023;20:1613.CrossRef
7.
go back to reference Domènech-Montoliu S, Puig-Barberá J, Badenes-Marques G, Gil-Fortuño M, Orrico-Sánchez A, Pac-Sa MR, et al. Long COVID prevalence and the impact of the third SARS-CoV-2 vaccine dose: a cross-sectional analysis from the third follow-up of the Borriana Cohort, Valencia, Spain (2020–2022). 2023. Domènech-Montoliu S, Puig-Barberá J, Badenes-Marques G, Gil-Fortuño M, Orrico-Sánchez A, Pac-Sa MR, et al. Long COVID prevalence and the impact of the third SARS-CoV-2 vaccine dose: a cross-sectional analysis from the third follow-up of the Borriana Cohort, Valencia, Spain (2020–2022). 2023.
8.
go back to reference Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med. 2022;28:1–7.CrossRef Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med. 2022;28:1–7.CrossRef
9.
go back to reference Jassat W, Mudara C, Vika C, Welch R, Arendse T, Dryden M, et al. A cohort study of post-COVID-19 condition across the Beta, Delta, and Omicron waves in South Africa: 6-month follow-up of hospitalized and nonhospitalized participants. Int J Infect Dis. 2023;128:102–11.PubMedPubMedCentralCrossRef Jassat W, Mudara C, Vika C, Welch R, Arendse T, Dryden M, et al. A cohort study of post-COVID-19 condition across the Beta, Delta, and Omicron waves in South Africa: 6-month follow-up of hospitalized and nonhospitalized participants. Int J Infect Dis. 2023;128:102–11.PubMedPubMedCentralCrossRef
10.
go back to reference Liao X, Guan Y, Liao Q, Ma Z, Zhang L, Dong J, et al. Long-term sequelae of different COVID-19 variants: the original strain versus the Omicron variant. Global Heal Medicine. 2022;4:322–6.CrossRef Liao X, Guan Y, Liao Q, Ma Z, Zhang L, Dong J, et al. Long-term sequelae of different COVID-19 variants: the original strain versus the Omicron variant. Global Heal Medicine. 2022;4:322–6.CrossRef
11.
go back to reference Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399:2263–4.PubMedPubMedCentralCrossRef Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399:2263–4.PubMedPubMedCentralCrossRef
12.
13.
go back to reference Fernández-de-las-Peñas C, Torres-Macho J, Catahay JA, Macasaet R, Velasco JV, Macapagal S, et al. Is antiviral treatment at the acute phase of COVID-19 effective for decreasing the risk of long-COVID? A systematic review. Infection. 2024;52:43–58.PubMedCrossRef Fernández-de-las-Peñas C, Torres-Macho J, Catahay JA, Macasaet R, Velasco JV, Macapagal S, et al. Is antiviral treatment at the acute phase of COVID-19 effective for decreasing the risk of long-COVID? A systematic review. Infection. 2024;52:43–58.PubMedCrossRef
14.
go back to reference Seeßle J, Waterboer T, Hippchen T, Simon J, Kirchner M, Lim A, et al. Persistent symptoms in adult patients 1 year after coronavirus disease 2019 (COVID-19): a prospective cohort study. Clin Infect Dis Official Publ Infect Dis Soc Am. 2021;74:1191–8.CrossRef Seeßle J, Waterboer T, Hippchen T, Simon J, Kirchner M, Lim A, et al. Persistent symptoms in adult patients 1 year after coronavirus disease 2019 (COVID-19): a prospective cohort study. Clin Infect Dis Official Publ Infect Dis Soc Am. 2021;74:1191–8.CrossRef
15.
go back to reference Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re’em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. Eclinicalmedicine. 2021;38:101019. Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re’em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. Eclinicalmedicine. 2021;38:101019.
16.
go back to reference Hartung TJ, Neumann C, Bahmer T, Chaplinskaya-Sobol I, Endres M, Geritz J, et al. Fatigue and cognitive impairment after COVID-19: a prospective multicentre study. eClinicalMedicine. 2022;53:101651.PubMedPubMedCentralCrossRef Hartung TJ, Neumann C, Bahmer T, Chaplinskaya-Sobol I, Endres M, Geritz J, et al. Fatigue and cognitive impairment after COVID-19: a prospective multicentre study. eClinicalMedicine. 2022;53:101651.PubMedPubMedCentralCrossRef
17.
go back to reference Hartung TJ, Bahmer T, Chaplinskaya-Sobol I, Deckert J, Endres M, Franzpötter K, et al. Predictors of non-recovery from fatigue and cognitive deficits after COVID-19: a prospective, longitudinal, population-based study. eClinicalMedicine. 2024;69:102456.PubMedPubMedCentralCrossRef Hartung TJ, Bahmer T, Chaplinskaya-Sobol I, Deckert J, Endres M, Franzpötter K, et al. Predictors of non-recovery from fatigue and cognitive deficits after COVID-19: a prospective, longitudinal, population-based study. eClinicalMedicine. 2024;69:102456.PubMedPubMedCentralCrossRef
18.
go back to reference Akbarialiabad H, Taghrir MH, Abdollahi A, Ghahramani N, Kumar M, Paydar S, et al. Long COVID, a comprehensive systematic scoping review. Infection. 2021;49:1–24.CrossRef Akbarialiabad H, Taghrir MH, Abdollahi A, Ghahramani N, Kumar M, Paydar S, et al. Long COVID, a comprehensive systematic scoping review. Infection. 2021;49:1–24.CrossRef
19.
go back to reference Twomey R, DeMars J, Franklin K, Culos-Reed SN, Weatherald J, Wrightson JG. Chronic fatigue and postexertional malaise in people living with long COVID: an observational study. Phys Ther 2022. Twomey R, DeMars J, Franklin K, Culos-Reed SN, Weatherald J, Wrightson JG. Chronic fatigue and postexertional malaise in people living with long COVID: an observational study. Phys Ther 2022.
22.
go back to reference Bonilla H, Quach TC, Tiwari A, Bonilla AE, Miglis M, Yang PC, et al. Myalgic encephalomyelitis/chronic fatigue syndrome is common in post-acute sequelae of SARS-CoV-2 infection (PASC): results from a post-COVID-19 multidisciplinary clinic. Front Neurol. 2023;14:1090747.PubMedPubMedCentralCrossRef Bonilla H, Quach TC, Tiwari A, Bonilla AE, Miglis M, Yang PC, et al. Myalgic encephalomyelitis/chronic fatigue syndrome is common in post-acute sequelae of SARS-CoV-2 infection (PASC): results from a post-COVID-19 multidisciplinary clinic. Front Neurol. 2023;14:1090747.PubMedPubMedCentralCrossRef
24.
go back to reference Kedor C, Freitag H, Meyer-Arndt L, Wittke K, Hanitsch LG, Zoller T, et al. A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity. Nat Commun. 2022;13:5104.PubMedPubMedCentralCrossRef Kedor C, Freitag H, Meyer-Arndt L, Wittke K, Hanitsch LG, Zoller T, et al. A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity. Nat Commun. 2022;13:5104.PubMedPubMedCentralCrossRef
25.
go back to reference Choutka J, Jansari V, Hornig M, Iwasaki A. Unexplained post-acute infection syndromes. Nat Med. 2022;28:911–23.PubMedCrossRef Choutka J, Jansari V, Hornig M, Iwasaki A. Unexplained post-acute infection syndromes. Nat Med. 2022;28:911–23.PubMedCrossRef
26.
go back to reference Unger ER, Lin J-MS, Wisk LE, Yu H, L’Hommedieu M, Lavretsky H, et al. Myalgic encephalomyelitis/chronic fatigue syndrome after SARS-CoV-2 infection. JAMA Netw Open. 2024;7:e2423555. Unger ER, Lin J-MS, Wisk LE, Yu H, L’Hommedieu M, Lavretsky H, et al. Myalgic encephalomyelitis/chronic fatigue syndrome after SARS-CoV-2 infection. JAMA Netw Open. 2024;7:e2423555.
27.
go back to reference Hartle M, Bateman L, Vernon SD. Dissecting the nature of post-exertional malaise. Fatigue Biomed Heal Behav. 2021;9:1–12. Hartle M, Bateman L, Vernon SD. Dissecting the nature of post-exertional malaise. Fatigue Biomed Heal Behav. 2021;9:1–12.
28.
go back to reference Holtzman CS, Bhatia S, Cotler J, Jason LA. Assessment of post-exertional malaise (PEM) in patients with myalgic encephalomyelitis (ME) and chronic fatigue syndrome (CFS): a patient-driven survey. Diagnostics. 2019;9:26.PubMedPubMedCentralCrossRef Holtzman CS, Bhatia S, Cotler J, Jason LA. Assessment of post-exertional malaise (PEM) in patients with myalgic encephalomyelitis (ME) and chronic fatigue syndrome (CFS): a patient-driven survey. Diagnostics. 2019;9:26.PubMedPubMedCentralCrossRef
29.
go back to reference Vernon SD, Hartle M, Sullivan K, Bell J, Abbaszadeh S, Unutmaz D, et al. Post-exertional malaise among people with long COVID compared to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Work. 2023;74:1–8.CrossRef Vernon SD, Hartle M, Sullivan K, Bell J, Abbaszadeh S, Unutmaz D, et al. Post-exertional malaise among people with long COVID compared to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Work. 2023;74:1–8.CrossRef
30.
go back to reference Chu L, Valencia IJ, Garvert DW, Montoya JG. Deconstructing post-exertional malaise in myalgic encephalomyelitis/ chronic fatigue syndrome: a patient-centered, cross-sectional survey. PLoS One. 2018;13: e0197811.PubMedPubMedCentralCrossRef Chu L, Valencia IJ, Garvert DW, Montoya JG. Deconstructing post-exertional malaise in myalgic encephalomyelitis/ chronic fatigue syndrome: a patient-centered, cross-sectional survey. PLoS One. 2018;13: e0197811.PubMedPubMedCentralCrossRef
31.
go back to reference Lim E-J, Kang E-B, Jang E-S, Son C-G. The prospects of the two-day cardiopulmonary exercise test (CPET) in ME/CFS patients: a meta-analysis. J Clin Med. 2020;9:4040.PubMedPubMedCentralCrossRef Lim E-J, Kang E-B, Jang E-S, Son C-G. The prospects of the two-day cardiopulmonary exercise test (CPET) in ME/CFS patients: a meta-analysis. J Clin Med. 2020;9:4040.PubMedPubMedCentralCrossRef
32.
go back to reference Jäkel B, Kedor C, Grabowski P, Wittke K, Thiel S, Scherbakov N, et al. Hand grip strength and fatigability: correlation with clinical parameters and diagnostic suitability in ME/CFS. J Transl Med. 2021;19:159.PubMedPubMedCentralCrossRef Jäkel B, Kedor C, Grabowski P, Wittke K, Thiel S, Scherbakov N, et al. Hand grip strength and fatigability: correlation with clinical parameters and diagnostic suitability in ME/CFS. J Transl Med. 2021;19:159.PubMedPubMedCentralCrossRef
33.
go back to reference Herold F, Müller P, Gronwald T, Müller NG. Dose-response matters! – a perspective on the exercise prescription in exercise-cognition research. Front Psychol. 2019;10:2338.PubMedPubMedCentralCrossRef Herold F, Müller P, Gronwald T, Müller NG. Dose-response matters! – a perspective on the exercise prescription in exercise-cognition research. Front Psychol. 2019;10:2338.PubMedPubMedCentralCrossRef
35.
go back to reference de Boer E, Petrache I, Goldstein NM, Olin JT, Keith RC, Modena B, et al. Decreased fatty acid oxidation and altered lactate production during exercise in patients with post-acute COVID-19 syndrome. Am J Resp Crit Care. 2021;205:126–9.CrossRef de Boer E, Petrache I, Goldstein NM, Olin JT, Keith RC, Modena B, et al. Decreased fatty acid oxidation and altered lactate production during exercise in patients with post-acute COVID-19 syndrome. Am J Resp Crit Care. 2021;205:126–9.CrossRef
36.
go back to reference Rinaldo RF, Mondoni M, Parazzini EM, Pitari F, Brambilla E, Luraschi S, et al. Deconditioning as main mechanism of impaired exercise response in COVID-19 survivors. Eur Respir J. 2021;58:2100870.PubMedPubMedCentralCrossRef Rinaldo RF, Mondoni M, Parazzini EM, Pitari F, Brambilla E, Luraschi S, et al. Deconditioning as main mechanism of impaired exercise response in COVID-19 survivors. Eur Respir J. 2021;58:2100870.PubMedPubMedCentralCrossRef
37.
go back to reference Skjørten I, Ankerstjerne OAW, Trebinjac D, Brønstad E, Rasch-Halvorsen Ø, Einvik G, et al. Cardiopulmonary exercise capacity and limitations 3 months after COVID-19 hospitalisation. Eur Respir J. 2021;58:2100996.PubMedPubMedCentralCrossRef Skjørten I, Ankerstjerne OAW, Trebinjac D, Brønstad E, Rasch-Halvorsen Ø, Einvik G, et al. Cardiopulmonary exercise capacity and limitations 3 months after COVID-19 hospitalisation. Eur Respir J. 2021;58:2100996.PubMedPubMedCentralCrossRef
38.
go back to reference Durstenfeld MS, Sun K, Tahir P, Peluso MJ, Deeks SG, Aras MA, et al. Use of cardiopulmonary exercise testing to evaluate long COVID-19 symptoms in adults. Jama Netw Open. 2022;5: e2236057.PubMedPubMedCentralCrossRef Durstenfeld MS, Sun K, Tahir P, Peluso MJ, Deeks SG, Aras MA, et al. Use of cardiopulmonary exercise testing to evaluate long COVID-19 symptoms in adults. Jama Netw Open. 2022;5: e2236057.PubMedPubMedCentralCrossRef
40.
go back to reference Joseph P, Singh I. Post-acute sequelae of SARS-CoV-2 more than deconditioning. Chest. 2023;164:583–4.PubMedCrossRef Joseph P, Singh I. Post-acute sequelae of SARS-CoV-2 more than deconditioning. Chest. 2023;164:583–4.PubMedCrossRef
41.
go back to reference Baratto C, Caravita S, Faini A, Perego GB, Senni M, Badano LP, et al. Impact of COVID-19 on exercise pathophysiology: a combined cardiopulmonary and echocardiographic exercise study. J Appl Physiol. 2021;130:1470–8.PubMedPubMedCentralCrossRef Baratto C, Caravita S, Faini A, Perego GB, Senni M, Badano LP, et al. Impact of COVID-19 on exercise pathophysiology: a combined cardiopulmonary and echocardiographic exercise study. J Appl Physiol. 2021;130:1470–8.PubMedPubMedCentralCrossRef
42.
43.
go back to reference Gremme Y, Derlien S, Katzer K, Reuken PA, Stallmach A, Lewejohann J-C, et al. Visualizing exertional dyspnea in a post-COVID patient using electrical impedance tomography. Infection. 2023;51:1841–5.PubMedPubMedCentralCrossRef Gremme Y, Derlien S, Katzer K, Reuken PA, Stallmach A, Lewejohann J-C, et al. Visualizing exertional dyspnea in a post-COVID patient using electrical impedance tomography. Infection. 2023;51:1841–5.PubMedPubMedCentralCrossRef
44.
go back to reference Singh I, Joseph P, Heerdt PM, Cullinan M, Lutchmansingh DD, Gulati M, et al. Persistent exertional intolerance after COVID-19: Insights from invasive cardiopulmonary exercise testing. Chest. 2021;161:54–63.PubMedCrossRef Singh I, Joseph P, Heerdt PM, Cullinan M, Lutchmansingh DD, Gulati M, et al. Persistent exertional intolerance after COVID-19: Insights from invasive cardiopulmonary exercise testing. Chest. 2021;161:54–63.PubMedCrossRef
45.
go back to reference Singh I, Leitner BP, Wang Y, Zhang H, Joseph P, Lutchmansingh DD, et al. Proteomic profiling demonstrates inflammatory and endotheliopathy signatures associated with impaired cardiopulmonary exercise hemodynamic profile in Post Acute Sequelae of SARS-CoV-2 infection (PASC) syndrome. Pulm Circ. 2023;13: e12220.PubMedPubMedCentralCrossRef Singh I, Leitner BP, Wang Y, Zhang H, Joseph P, Lutchmansingh DD, et al. Proteomic profiling demonstrates inflammatory and endotheliopathy signatures associated with impaired cardiopulmonary exercise hemodynamic profile in Post Acute Sequelae of SARS-CoV-2 infection (PASC) syndrome. Pulm Circ. 2023;13: e12220.PubMedPubMedCentralCrossRef
46.
go back to reference Kahn PA, Joseph P, Heerdt PM, Singh I. Differential cardiopulmonary haemodynamic phenotypes in PASC-related exercise intolerance. ERJ Open Res. 2024;10:00714–2023.PubMedPubMedCentralCrossRef Kahn PA, Joseph P, Heerdt PM, Singh I. Differential cardiopulmonary haemodynamic phenotypes in PASC-related exercise intolerance. ERJ Open Res. 2024;10:00714–2023.PubMedPubMedCentralCrossRef
47.
go back to reference Joseph P, Singh I, Oliveira R, Capone CA, Mullen MP, Cook DB, et al. Exercise pathophysiology in myalgic encephalomyelitis/chronic fatigue syndrome and postacute sequelae of SARS-CoV-2 more in common than not? Chest. 2023;164:717–26.PubMedPubMedCentralCrossRef Joseph P, Singh I, Oliveira R, Capone CA, Mullen MP, Cook DB, et al. Exercise pathophysiology in myalgic encephalomyelitis/chronic fatigue syndrome and postacute sequelae of SARS-CoV-2 more in common than not? Chest. 2023;164:717–26.PubMedPubMedCentralCrossRef
48.
go back to reference Appelman B, Charlton BT, Goulding RP, Kerkhoff TJ, Breedveld EA, Noort W, et al. Muscle abnormalities worsen after post-exertional malaise in long COVID. Nat Commun. 2024;15:17.PubMedPubMedCentralCrossRef Appelman B, Charlton BT, Goulding RP, Kerkhoff TJ, Breedveld EA, Noort W, et al. Muscle abnormalities worsen after post-exertional malaise in long COVID. Nat Commun. 2024;15:17.PubMedPubMedCentralCrossRef
49.
go back to reference Aschman T, Wyler E, Baum O, Hentschel A, Legler F, Preusse C, et al. Post-COVID syndrome is associated with capillary alterations, macrophage infiltration and distinct transcriptomic signatures in skeletal muscles. 2023;21:e68. Aschman T, Wyler E, Baum O, Hentschel A, Legler F, Preusse C, et al. Post-COVID syndrome is associated with capillary alterations, macrophage infiltration and distinct transcriptomic signatures in skeletal muscles. 2023;21:e68.
50.
go back to reference Bizjak DA, Ohmayer B, Buhl JL, Schneider EM, Walther P, Calzia E, et al. Functional and morphological differences of muscle mitochondria in chronic fatigue syndrome and Post-COVID syndrome. Int J Mol Sci. 2024;25:1675.PubMedPubMedCentralCrossRef Bizjak DA, Ohmayer B, Buhl JL, Schneider EM, Walther P, Calzia E, et al. Functional and morphological differences of muscle mitochondria in chronic fatigue syndrome and Post-COVID syndrome. Int J Mol Sci. 2024;25:1675.PubMedPubMedCentralCrossRef
51.
go back to reference Hejbøl EK, Harbo T, Agergaard J, Madsen LB, Pedersen TH, Østergaard LJ, et al. Myopathy as a cause of fatigue in long-term post-COVID-19 symptoms: evidence of skeletal muscle histopathology. Eur J Neurol. 2022;29:2832–41.PubMedCrossRef Hejbøl EK, Harbo T, Agergaard J, Madsen LB, Pedersen TH, Østergaard LJ, et al. Myopathy as a cause of fatigue in long-term post-COVID-19 symptoms: evidence of skeletal muscle histopathology. Eur J Neurol. 2022;29:2832–41.PubMedCrossRef
52.
go back to reference Wang P, Ma J, Kim Y-C, Son AY, Syed AM, Liu C, et al. WASF3 disrupts mitochondrial respiration and may mediate exercise intolerance in myalgic encephalomyelitis/chronic fatigue syndrome. Proc Natl Acad Sci. 2023;120: e2302738120.PubMedPubMedCentralCrossRef Wang P, Ma J, Kim Y-C, Son AY, Syed AM, Liu C, et al. WASF3 disrupts mitochondrial respiration and may mediate exercise intolerance in myalgic encephalomyelitis/chronic fatigue syndrome. Proc Natl Acad Sci. 2023;120: e2302738120.PubMedPubMedCentralCrossRef
53.
go back to reference Guntur VP, Nemkov T, de Boer E, Mohning MP, Baraghoshi D, Cendali FI, et al. Signatures of mitochondrial dysfunction and impaired fatty acid metabolism in plasma of patients with post-acute sequelae of COVID-19 (PASC). Metabolites. 2022;12:1026.PubMedPubMedCentralCrossRef Guntur VP, Nemkov T, de Boer E, Mohning MP, Baraghoshi D, Cendali FI, et al. Signatures of mitochondrial dysfunction and impaired fatty acid metabolism in plasma of patients with post-acute sequelae of COVID-19 (PASC). Metabolites. 2022;12:1026.PubMedPubMedCentralCrossRef
55.
56.
57.
go back to reference Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19. New Engl J Med. 2020;383:120–8.PubMedCrossRef Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19. New Engl J Med. 2020;383:120–8.PubMedCrossRef
58.
go back to reference Charfeddine S, Amor HIH, Jdidi J, Torjmen S, Kraiem S, Hammami R, et al. Long COVID 19 syndrome: is it related to microcirculation and endothelial dysfunction? Insights from TUN-EndCOV study. Frontiers Cardiovasc Medicine. 2021;8: 745758.CrossRef Charfeddine S, Amor HIH, Jdidi J, Torjmen S, Kraiem S, Hammami R, et al. Long COVID 19 syndrome: is it related to microcirculation and endothelial dysfunction? Insights from TUN-EndCOV study. Frontiers Cardiovasc Medicine. 2021;8: 745758.CrossRef
59.
go back to reference Nicolai L, Kaiser R, Stark K. Thromboinflammation in long COVID—the elusive key to postinfection sequelae? J Thromb Haemost. 2023;21:2020–31.PubMedCrossRef Nicolai L, Kaiser R, Stark K. Thromboinflammation in long COVID—the elusive key to postinfection sequelae? J Thromb Haemost. 2023;21:2020–31.PubMedCrossRef
60.
go back to reference Poyatos P, Luque N, Sabater G, Eizaguirre S, Bonnin M, Orriols R, et al. Endothelial dysfunction and cardiovascular risk in post-COVID-19 patients after 6- and 12-months SARS-CoV-2 infection. Infection. 2024;52:1269–85.PubMedPubMedCentralCrossRef Poyatos P, Luque N, Sabater G, Eizaguirre S, Bonnin M, Orriols R, et al. Endothelial dysfunction and cardiovascular risk in post-COVID-19 patients after 6- and 12-months SARS-CoV-2 infection. Infection. 2024;52:1269–85.PubMedPubMedCentralCrossRef
61.
go back to reference Ambrosino P, Calcaterra I, Molino A, Moretta P, Lupoli R, Spedicato GA, et al. Persistent endothelial dysfunction in post-acute COVID-19 syndrome: a case-control study. Biomed. 2021;9:957. Ambrosino P, Calcaterra I, Molino A, Moretta P, Lupoli R, Spedicato GA, et al. Persistent endothelial dysfunction in post-acute COVID-19 syndrome: a case-control study. Biomed. 2021;9:957.
62.
go back to reference Ambrosino P, Parrella P, Formisano R, Perrotta G, D’Anna SE, Mosella M, et al. Cardiopulmonary exercise performance and endothelial function in convalescent COVID-19 patients. J Clin Medicine. 2022;11:1452.CrossRef Ambrosino P, Parrella P, Formisano R, Perrotta G, D’Anna SE, Mosella M, et al. Cardiopulmonary exercise performance and endothelial function in convalescent COVID-19 patients. J Clin Medicine. 2022;11:1452.CrossRef
63.
go back to reference Prasannan N, Heightman M, Hillman T, Wall E, Bell R, Kessler A, et al. Impaired exercise capacity in post–COVID-19 syndrome: the role of VWF-ADAMTS13 axis. Blood Adv. 2022;6:4041–8.PubMedPubMedCentralCrossRef Prasannan N, Heightman M, Hillman T, Wall E, Bell R, Kessler A, et al. Impaired exercise capacity in post–COVID-19 syndrome: the role of VWF-ADAMTS13 axis. Blood Adv. 2022;6:4041–8.PubMedPubMedCentralCrossRef
65.
go back to reference López-Hernández Y, Monárrez-Espino J, López DAG, Zheng J, Borrego JC, Torres-Calzada C, et al. The plasma metabolome of long COVID patients two years after infection. Sci Rep. 2023;13:12420.PubMedPubMedCentralCrossRef López-Hernández Y, Monárrez-Espino J, López DAG, Zheng J, Borrego JC, Torres-Calzada C, et al. The plasma metabolome of long COVID patients two years after infection. Sci Rep. 2023;13:12420.PubMedPubMedCentralCrossRef
66.
go back to reference Calvani R, Gervasoni J, Picca A, Ciciarello F, Galluzzo V, Coelho-Júnior HJ, et al. Effects of l-arginine plus Vitamin C supplementation on l-arginine metabolism in adults with long COVID: secondary analysis of a randomized clinical trial. Int J Mol Sci. 2023;24:5078.PubMedPubMedCentralCrossRef Calvani R, Gervasoni J, Picca A, Ciciarello F, Galluzzo V, Coelho-Júnior HJ, et al. Effects of l-arginine plus Vitamin C supplementation on l-arginine metabolism in adults with long COVID: secondary analysis of a randomized clinical trial. Int J Mol Sci. 2023;24:5078.PubMedPubMedCentralCrossRef
67.
go back to reference Bertinat R, Villalobos-Labra R, Hofmann L, Blauensteiner J, Sepúlveda N, Westermeier F. Decreased no production in endothelial cells exposed to plasma from ME/CFS patients. Vasc Pharmacol. 2022;143: 106953.CrossRef Bertinat R, Villalobos-Labra R, Hofmann L, Blauensteiner J, Sepúlveda N, Westermeier F. Decreased no production in endothelial cells exposed to plasma from ME/CFS patients. Vasc Pharmacol. 2022;143: 106953.CrossRef
68.
go back to reference Tosato M, Calvani R, Picca A, Ciciarello F, Galluzzo V, Coelho-Júnior HJ, et al. Effects of l-arginine plus Vitamin C supplementation on physical performance, endothelial function, and persistent fatigue in adults with Long COVID: a single-blind randomized controlled trial. Nutrients. 2022;14:4984.PubMedPubMedCentralCrossRef Tosato M, Calvani R, Picca A, Ciciarello F, Galluzzo V, Coelho-Júnior HJ, et al. Effects of l-arginine plus Vitamin C supplementation on physical performance, endothelial function, and persistent fatigue in adults with Long COVID: a single-blind randomized controlled trial. Nutrients. 2022;14:4984.PubMedPubMedCentralCrossRef
69.
go back to reference Izzo R, Trimarco V, Mone P, Aloè T, Marzani MC, Diana A, et al. Combining L-arginine with vitamin C improves long-COVID symptoms: The LINCOLN survey. Pharmacol Res. 2022;183: 106360.PubMedPubMedCentralCrossRef Izzo R, Trimarco V, Mone P, Aloè T, Marzani MC, Diana A, et al. Combining L-arginine with vitamin C improves long-COVID symptoms: The LINCOLN survey. Pharmacol Res. 2022;183: 106360.PubMedPubMedCentralCrossRef
70.
go back to reference Flaskamp L, Roubal C, Uddin S, Sotzny F, Kedor C, Bauer S, et al. Serum of post-COVID-19 syndrome patients with or without ME/CFS differentially affects endothelial cell function in vitro. Cells. 2022;11:2376.PubMedPubMedCentralCrossRef Flaskamp L, Roubal C, Uddin S, Sotzny F, Kedor C, Bauer S, et al. Serum of post-COVID-19 syndrome patients with or without ME/CFS differentially affects endothelial cell function in vitro. Cells. 2022;11:2376.PubMedPubMedCentralCrossRef
71.
go back to reference Aschman T, Wyler E, Baum O, Hentschel A, Rust R, Legler F, et al. Post-COVID exercise intolerance is associated with capillary alterations and immune dysregulations in skeletal muscles. Acta Neuropathol Commun. 2023;11:193.PubMedPubMedCentralCrossRef Aschman T, Wyler E, Baum O, Hentschel A, Rust R, Legler F, et al. Post-COVID exercise intolerance is associated with capillary alterations and immune dysregulations in skeletal muscles. Acta Neuropathol Commun. 2023;11:193.PubMedPubMedCentralCrossRef
72.
go back to reference Turner S, Khan MA, Putrino D, Woodcock A, Kell DB, Pretorius E. Long COVID: pathophysiological factors and abnormalities of coagulation. Trends Endocrinol Metab. 2023;34:321–44.PubMedPubMedCentralCrossRef Turner S, Khan MA, Putrino D, Woodcock A, Kell DB, Pretorius E. Long COVID: pathophysiological factors and abnormalities of coagulation. Trends Endocrinol Metab. 2023;34:321–44.PubMedPubMedCentralCrossRef
73.
go back to reference Pretorius E, Vlok M, Venter C, Bezuidenhout JA, Laubscher GJ, Steenkamp J, et al. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc Diabetol. 2021;20:172.PubMedPubMedCentralCrossRef Pretorius E, Vlok M, Venter C, Bezuidenhout JA, Laubscher GJ, Steenkamp J, et al. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc Diabetol. 2021;20:172.PubMedPubMedCentralCrossRef
74.
go back to reference Constantinescu-Bercu A, Kessler A, de Groot R, Dragunaite B, Heightman M, Hillman T, et al. Analysis of thrombogenicity under flow reveals new insights into the prothrombotic state of patients with post-COVID syndrome. J Thromb Haemost. 2023;21:94–100.PubMedCrossRef Constantinescu-Bercu A, Kessler A, de Groot R, Dragunaite B, Heightman M, Hillman T, et al. Analysis of thrombogenicity under flow reveals new insights into the prothrombotic state of patients with post-COVID syndrome. J Thromb Haemost. 2023;21:94–100.PubMedCrossRef
75.
go back to reference Giloteaux L, Glass KA, Germain A, Franconi CJ, Zhang S, Hanson MR. Dysregulation of extracellular vesicle protein cargo in female myalgic encephalomyelitis/chronic fatigue syndrome cases and sedentary controls in response to maximal exercise. J Extracell Vesicles. 2024;13:12403.PubMedPubMedCentralCrossRef Giloteaux L, Glass KA, Germain A, Franconi CJ, Zhang S, Hanson MR. Dysregulation of extracellular vesicle protein cargo in female myalgic encephalomyelitis/chronic fatigue syndrome cases and sedentary controls in response to maximal exercise. J Extracell Vesicles. 2024;13:12403.PubMedPubMedCentralCrossRef
76.
go back to reference Wirth KJ, Löhn M. Microvascular capillary and precapillary cardiovascular disturbances strongly interact to severely affect tissue perfusion and mitochondrial function in myalgic encephalomyelitis/chronic fatigue syndrome evolving from the post COVID-19 syndrome. Medicina. 2024;60:194.PubMedPubMedCentralCrossRef Wirth KJ, Löhn M. Microvascular capillary and precapillary cardiovascular disturbances strongly interact to severely affect tissue perfusion and mitochondrial function in myalgic encephalomyelitis/chronic fatigue syndrome evolving from the post COVID-19 syndrome. Medicina. 2024;60:194.PubMedPubMedCentralCrossRef
77.
go back to reference Kell DB, Pretorius E. The potential role of ischaemia–reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications. Biochem J. 2022;479:1653–708.PubMedCrossRef Kell DB, Pretorius E. The potential role of ischaemia–reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications. Biochem J. 2022;479:1653–708.PubMedCrossRef
78.
go back to reference Makris KI, Nella AA, Zhu Z, Swanson SA, Casale GP, Gutti TL, et al. Mitochondriopathy of peripheral arterial disease. Vascular. 2007;15:336–43.PubMedCrossRef Makris KI, Nella AA, Zhu Z, Swanson SA, Casale GP, Gutti TL, et al. Mitochondriopathy of peripheral arterial disease. Vascular. 2007;15:336–43.PubMedCrossRef
80.
go back to reference Nunes JM, Kell DB, Pretorius E. Cardiovascular and haematological pathology in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a role for viruses. Blood Rev. 2023;60: 101075.PubMedPubMedCentralCrossRef Nunes JM, Kell DB, Pretorius E. Cardiovascular and haematological pathology in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a role for viruses. Blood Rev. 2023;60: 101075.PubMedPubMedCentralCrossRef
81.
go back to reference Böning D, Kuebler WM, Vogel D, Bloch W. The oxygen dissociation curve of blood in COVID-19–an update. Front Med. 2023;10:1098547.CrossRef Böning D, Kuebler WM, Vogel D, Bloch W. The oxygen dissociation curve of blood in COVID-19–an update. Front Med. 2023;10:1098547.CrossRef
82.
go back to reference Joseph P, Arevalo C, Oliveira RKF, Faria-Urbina M, Felsenstein D, Oaklander AL, et al. Insights from invasive cardiopulmonary exercise testing of patients with myalgic encephalomyelitis/chronic fatigue syndrome. Chest. 2021;160:642–51.PubMedPubMedCentralCrossRef Joseph P, Arevalo C, Oliveira RKF, Faria-Urbina M, Felsenstein D, Oaklander AL, et al. Insights from invasive cardiopulmonary exercise testing of patients with myalgic encephalomyelitis/chronic fatigue syndrome. Chest. 2021;160:642–51.PubMedPubMedCentralCrossRef
83.
go back to reference Sotzny F, Blanco J, Capelli E, Castro-Marrero J, Steiner S, Murovska M, et al. Myalgic encephalomyelitis/chronic fatigue syndrome – evidence for an autoimmune disease. Autoimmun Rev. 2018;17:601–9.PubMedCrossRef Sotzny F, Blanco J, Capelli E, Castro-Marrero J, Steiner S, Murovska M, et al. Myalgic encephalomyelitis/chronic fatigue syndrome – evidence for an autoimmune disease. Autoimmun Rev. 2018;17:601–9.PubMedCrossRef
84.
go back to reference Fajloun Z, Khattar ZA, Kovacic H, Legros C, Sabatier J-M. Why do athletes develop very severe or fatal forms of COVID after intense exercise following SARS-CoV-2 infection or anti-COVID vaccination? Infect Disord - Drug Targets. 2023;23:E110123212563.PubMedCrossRef Fajloun Z, Khattar ZA, Kovacic H, Legros C, Sabatier J-M. Why do athletes develop very severe or fatal forms of COVID after intense exercise following SARS-CoV-2 infection or anti-COVID vaccination? Infect Disord - Drug Targets. 2023;23:E110123212563.PubMedCrossRef
85.
86.
go back to reference Files JK, Sarkar S, Fram. TR, Boppana S, Sterrett S, Qin K, et al. Duration of post-COVID-19 symptoms are associated with sustained SARS-CoV-2 specific immune responses. JCI Insight. 2021. Files JK, Sarkar S, Fram. TR, Boppana S, Sterrett S, Qin K, et al. Duration of post-COVID-19 symptoms are associated with sustained SARS-CoV-2 specific immune responses. JCI Insight. 2021.
87.
go back to reference Krishna BA, Lim EY, Metaxaki M, Jackson S, Mactavous L, BioResource N, et al. Spontaneous, persistent, T cell–dependent IFN-γ release in patients who progress to Long Covid. Sci Adv. 2024;10:eadie379.CrossRef Krishna BA, Lim EY, Metaxaki M, Jackson S, Mactavous L, BioResource N, et al. Spontaneous, persistent, T cell–dependent IFN-γ release in patients who progress to Long Covid. Sci Adv. 2024;10:eadie379.CrossRef
88.
go back to reference Sbierski-Kind J, Schlickeiser S, Feldmann S, Ober V, Grüner E, Pleimelding C, et al. Persistent immune abnormalities discriminate post-COVID syndrome from convalescence. Infection. 2024;52:1087–97.PubMedPubMedCentralCrossRef Sbierski-Kind J, Schlickeiser S, Feldmann S, Ober V, Grüner E, Pleimelding C, et al. Persistent immune abnormalities discriminate post-COVID syndrome from convalescence. Infection. 2024;52:1087–97.PubMedPubMedCentralCrossRef
89.
go back to reference Pink I, Hennigs JK, Ruhl L, Sauer A, Boblitz L, Huwe M, et al. Blood T cell phenotypes correlate with fatigue severity in post-acute sequelae of COVID-19. Infection. 2024;52:513–24.PubMedCrossRef Pink I, Hennigs JK, Ruhl L, Sauer A, Boblitz L, Huwe M, et al. Blood T cell phenotypes correlate with fatigue severity in post-acute sequelae of COVID-19. Infection. 2024;52:513–24.PubMedCrossRef
90.
go back to reference Yin K, Peluso MJ, Luo X, Thomas R, Shin M-G, Neidleman J, et al. Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2. Nat Immunol. 2024;25:218–25.PubMedPubMedCentralCrossRef Yin K, Peluso MJ, Luo X, Thomas R, Shin M-G, Neidleman J, et al. Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2. Nat Immunol. 2024;25:218–25.PubMedPubMedCentralCrossRef
91.
go back to reference Swank Z, Senussi Y, Manickas-Hill Z, Yu XG, Li JZ, Alter G, et al. Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae. Clin Infect Dis. 2022;76:e487–90.PubMedCentralCrossRef Swank Z, Senussi Y, Manickas-Hill Z, Yu XG, Li JZ, Alter G, et al. Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae. Clin Infect Dis. 2022;76:e487–90.PubMedCentralCrossRef
92.
go back to reference Craddock V, Mahajan A, Spikes L, Krishnamachary B, Ram AK, Kumar A, et al. Persistent circulation of soluble and extracellular vesicle-linked Spike protein in individuals with postacute sequelae of COVID-19. J Méd Virol. 2023;95: e28568.PubMedPubMedCentralCrossRef Craddock V, Mahajan A, Spikes L, Krishnamachary B, Ram AK, Kumar A, et al. Persistent circulation of soluble and extracellular vesicle-linked Spike protein in individuals with postacute sequelae of COVID-19. J Méd Virol. 2023;95: e28568.PubMedPubMedCentralCrossRef
93.
go back to reference Haunhorst S, Bloch W, Wagner H, Ellert C, Krüger K, Vilser DC, et al. Long COVID: a narrative review of the clinical aftermaths of COVID-19 with a focus on the putative pathophysiology and aspects of physical activity. Oxf Open Immunol. 2022;3:iqac006.PubMedPubMedCentralCrossRef Haunhorst S, Bloch W, Wagner H, Ellert C, Krüger K, Vilser DC, et al. Long COVID: a narrative review of the clinical aftermaths of COVID-19 with a focus on the putative pathophysiology and aspects of physical activity. Oxf Open Immunol. 2022;3:iqac006.PubMedPubMedCentralCrossRef
94.
go back to reference Gyöngyösi M, Lukovic D, Mester-Tonczar J, Zlabinger K, Einzinger P, Spannbauer A, et al. Effect of monovalent COVID-19 vaccines on viral interference between SARS-CoV-2 and several DNA viruses in patients with long-COVID syndrome. NPJ Vaccines. 2023;8:145.PubMedPubMedCentralCrossRef Gyöngyösi M, Lukovic D, Mester-Tonczar J, Zlabinger K, Einzinger P, Spannbauer A, et al. Effect of monovalent COVID-19 vaccines on viral interference between SARS-CoV-2 and several DNA viruses in patients with long-COVID syndrome. NPJ Vaccines. 2023;8:145.PubMedPubMedCentralCrossRef
95.
go back to reference Klein J, Wood J, Jaycox JR, Dhodapkar RM, Lu P, Gehlhausen JR, et al. Distinguishing features of long COVID identified through immune profiling. Nature. 2023;623:139–48.PubMedPubMedCentralCrossRef Klein J, Wood J, Jaycox JR, Dhodapkar RM, Lu P, Gehlhausen JR, et al. Distinguishing features of long COVID identified through immune profiling. Nature. 2023;623:139–48.PubMedPubMedCentralCrossRef
96.
go back to reference Missailidis D, Annesley SJ, Allan CY, Sanislav O, Lidbury BA, Lewis DP, et al. An isolated complex V inefficiency and dysregulated mitochondrial function in immortalized lymphocytes from ME/CFS patients. Int J Mol Sci. 2020;21:1074.PubMedPubMedCentralCrossRef Missailidis D, Annesley SJ, Allan CY, Sanislav O, Lidbury BA, Lewis DP, et al. An isolated complex V inefficiency and dysregulated mitochondrial function in immortalized lymphocytes from ME/CFS patients. Int J Mol Sci. 2020;21:1074.PubMedPubMedCentralCrossRef
97.
go back to reference Tomas C, Elson JL, Strassheim V, Newton JL, Walker M. The effect of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) severity on cellular bioenergetic function. PLoS One. 2020;15: e0231136.PubMedPubMedCentralCrossRef Tomas C, Elson JL, Strassheim V, Newton JL, Walker M. The effect of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) severity on cellular bioenergetic function. PLoS One. 2020;15: e0231136.PubMedPubMedCentralCrossRef
98.
go back to reference Missailidis D, Sanislav O, Allan CY, Smith PK, Annesley SJ, Fisher PR. Dysregulated provision of oxidisable substrates to the mitochondria in ME/CFS lymphoblasts. Int J Mol Sci. 2021;22:2046.PubMedPubMedCentralCrossRef Missailidis D, Sanislav O, Allan CY, Smith PK, Annesley SJ, Fisher PR. Dysregulated provision of oxidisable substrates to the mitochondria in ME/CFS lymphoblasts. Int J Mol Sci. 2021;22:2046.PubMedPubMedCentralCrossRef
99.
go back to reference Maya J, Leddy SM, Gottschalk CG, Peterson DL, Hanson MR. Altered fatty acid oxidation in lymphocyte populations of myalgic encephalomyelitis/chronic fatigue syndrome. Int J Mol Sci. 2023;24:2010.PubMedPubMedCentralCrossRef Maya J, Leddy SM, Gottschalk CG, Peterson DL, Hanson MR. Altered fatty acid oxidation in lymphocyte populations of myalgic encephalomyelitis/chronic fatigue syndrome. Int J Mol Sci. 2023;24:2010.PubMedPubMedCentralCrossRef
100.
go back to reference Raizen DM, Mullington J, Anaclet C, Clarke G, Critchley H, Dantzer R, et al. Beyond the symptom: the biology of fatigue. Sleep. 2023;46:1–13.CrossRef Raizen DM, Mullington J, Anaclet C, Clarke G, Critchley H, Dantzer R, et al. Beyond the symptom: the biology of fatigue. Sleep. 2023;46:1–13.CrossRef
101.
go back to reference Villacampa A, Alfaro E, Morales C, Díaz-García E, López-Fernández C, Bartha JL, et al. SARS-CoV-2 S protein activates NLRP3 inflammasome and deregulates coagulation factors in endothelial and immune cells. Cell Commun Signal. 2024;22:38.PubMedPubMedCentralCrossRef Villacampa A, Alfaro E, Morales C, Díaz-García E, López-Fernández C, Bartha JL, et al. SARS-CoV-2 S protein activates NLRP3 inflammasome and deregulates coagulation factors in endothelial and immune cells. Cell Commun Signal. 2024;22:38.PubMedPubMedCentralCrossRef
102.
go back to reference Montezano AC, Camargo LL, Mary S, Neves KB, Rios FJ, Stein R, et al. SARS-CoV-2 spike protein induces endothelial inflammation via ACE2 independently of viral replication. Sci Rep. 2023;13:14086.PubMedPubMedCentralCrossRef Montezano AC, Camargo LL, Mary S, Neves KB, Rios FJ, Stein R, et al. SARS-CoV-2 spike protein induces endothelial inflammation via ACE2 independently of viral replication. Sci Rep. 2023;13:14086.PubMedPubMedCentralCrossRef
103.
go back to reference Grobbelaar LM, Venter C, Vlok M, Ngoepe M, Laubscher GJ, Lourens PJ, et al. SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19. 2021. Biosci Rep. https://doi.org/10.1042/BSR20210611. Grobbelaar LM, Venter C, Vlok M, Ngoepe M, Laubscher GJ, Lourens PJ, et al. SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19. 2021. Biosci Rep. https://​doi.​org/​10.​1042/​BSR20210611.
104.
go back to reference Scheppke KA, Pepe PE, Jui J, Crowe RP, Scheppke EK, Klimas NG, et al. Remission of severe forms of long COVID following monoclonal antibody (MCA) infusions: a report of signal index cases and call for targeted research. Am J Emerg Med. 2024;75:122–7.PubMedCrossRef Scheppke KA, Pepe PE, Jui J, Crowe RP, Scheppke EK, Klimas NG, et al. Remission of severe forms of long COVID following monoclonal antibody (MCA) infusions: a report of signal index cases and call for targeted research. Am J Emerg Med. 2024;75:122–7.PubMedCrossRef
105.
go back to reference Berezhnoy G, Bissinger R, Liu A, Cannet C, Schäfer H, Kienzle K, et al. Maintained imbalance of triglycerides, apolipoproteins, energy metabolites and cytokines in long-term COVID-19 syndrome patients. Front Immunol. 2023;14:1144224.PubMedPubMedCentralCrossRef Berezhnoy G, Bissinger R, Liu A, Cannet C, Schäfer H, Kienzle K, et al. Maintained imbalance of triglycerides, apolipoproteins, energy metabolites and cytokines in long-term COVID-19 syndrome patients. Front Immunol. 2023;14:1144224.PubMedPubMedCentralCrossRef
106.
go back to reference Ghali A, Lacout C, Ghali M, Gury A, Beucher A-B, Lozac’h P, et al. Elevated blood lactate in resting conditions correlate with post-exertional malaise severity in patients with Myalgic encephalomyelitis/Chronic fatigue syndrome. Sci Rep. 2019;9:18817. Ghali A, Lacout C, Ghali M, Gury A, Beucher A-B, Lozac’h P, et al. Elevated blood lactate in resting conditions correlate with post-exertional malaise severity in patients with Myalgic encephalomyelitis/Chronic fatigue syndrome. Sci Rep. 2019;9:18817.
107.
go back to reference Paul BD, Lemle MD, Komaroff AL, Snyder SH. Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome. Proc National Acad Sci. 2021;118: e2024358118.CrossRef Paul BD, Lemle MD, Komaroff AL, Snyder SH. Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome. Proc National Acad Sci. 2021;118: e2024358118.CrossRef
108.
go back to reference Walker M, Hall K, Peppercorn K, Tate W. The significance of oxidative stress in the pathophysiology of long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Méd Res Arch. 2022;10. Walker M, Hall K, Peppercorn K, Tate W. The significance of oxidative stress in the pathophysiology of long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Méd Res Arch. 2022;10.
109.
go back to reference McGarry T, Biniecka M, Veale DJ, Fearon U. Hypoxia, oxidative stress and inflammation. Free Radic Biol Med. 2018;125:15–24.PubMedCrossRef McGarry T, Biniecka M, Veale DJ, Fearon U. Hypoxia, oxidative stress and inflammation. Free Radic Biol Med. 2018;125:15–24.PubMedCrossRef
110.
go back to reference Haunhorst S, Bloch W, Ringleb M, Fennen L, Wagner H, Gabriel HHW, et al. Acute effects of heavy resistance exercise on biomarkers of neuroendocrine-immune regulation in healthy adults: a systematic review. Exerc Immunol Rev. 2022;28:36–52.PubMed Haunhorst S, Bloch W, Ringleb M, Fennen L, Wagner H, Gabriel HHW, et al. Acute effects of heavy resistance exercise on biomarkers of neuroendocrine-immune regulation in healthy adults: a systematic review. Exerc Immunol Rev. 2022;28:36–52.PubMed
111.
go back to reference Ringleb M, Javelle F, Haunhorst S, Bloch W, Fennen L, Baumgart S, et al. Beyond muscles: Investigating immunoregulatory myokines in acute resistance exercise – a systematic review and meta-analysis. FASEB J. 2024;38: e23596.PubMedCrossRef Ringleb M, Javelle F, Haunhorst S, Bloch W, Fennen L, Baumgart S, et al. Beyond muscles: Investigating immunoregulatory myokines in acute resistance exercise – a systematic review and meta-analysis. FASEB J. 2024;38: e23596.PubMedCrossRef
112.
go back to reference McManimen SL, Sunnquist ML, Jason LA. Deconstructing post-exertional malaise: an exploratory factor analysis. J Heal Psychol. 2019;24:188–98.CrossRef McManimen SL, Sunnquist ML, Jason LA. Deconstructing post-exertional malaise: an exploratory factor analysis. J Heal Psychol. 2019;24:188–98.CrossRef
113.
go back to reference Morris G, Maes M. Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways. Metab Brain Dis. 2014;29:19–36.PubMedCrossRef Morris G, Maes M. Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways. Metab Brain Dis. 2014;29:19–36.PubMedCrossRef
114.
go back to reference Petter E, Scheibenbogen C, Linz P, Stehning C, Wirth K, Kuehne T, et al. Muscle sodium content in patients with myalgic encephalomyelitis/chronic fatigue syndrome. J Transl Med. 2022;20:580.PubMedPubMedCentralCrossRef Petter E, Scheibenbogen C, Linz P, Stehning C, Wirth K, Kuehne T, et al. Muscle sodium content in patients with myalgic encephalomyelitis/chronic fatigue syndrome. J Transl Med. 2022;20:580.PubMedPubMedCentralCrossRef
115.
go back to reference Wirth KJ, Scheibenbogen C. Pathophysiology of skeletal muscle disturbances in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). J Transl Med. 2021;19:162.PubMedPubMedCentralCrossRef Wirth KJ, Scheibenbogen C. Pathophysiology of skeletal muscle disturbances in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). J Transl Med. 2021;19:162.PubMedPubMedCentralCrossRef
117.
go back to reference Greene C, Connolly R, Brennan D, Laffan A, O’Keeffe E, Zaporojan L, et al. Blood–brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment. Nat Neurosci. 2024;27:421–32.PubMedPubMedCentralCrossRef Greene C, Connolly R, Brennan D, Laffan A, O’Keeffe E, Zaporojan L, et al. Blood–brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment. Nat Neurosci. 2024;27:421–32.PubMedPubMedCentralCrossRef
118.
go back to reference Low RN, Low RJ, Akrami A. A review of cytokine-based pathophysiology of Long COVID symptoms. Front Med. 2023;10:1011936.CrossRef Low RN, Low RJ, Akrami A. A review of cytokine-based pathophysiology of Long COVID symptoms. Front Med. 2023;10:1011936.CrossRef
119.
go back to reference White AT, Light AR, Hughen RW, Bateman L, Martins TB, Hill HR, et al. Severity of symptom flare after moderate exercise is linked to cytokine activity in chronic fatigue syndrome. Psychophysiology. 2010;47:615–24.PubMedPubMedCentral White AT, Light AR, Hughen RW, Bateman L, Martins TB, Hill HR, et al. Severity of symptom flare after moderate exercise is linked to cytokine activity in chronic fatigue syndrome. Psychophysiology. 2010;47:615–24.PubMedPubMedCentral
120.
go back to reference Tsilioni I, Natelson B, Theoharides TC. Exosome-associated mitochondrial DNA from patients with myalgic encephalomyelitis/chronic fatigue syndrome stimulates human microglia to release IL-1β. Eur J Neurosci. 2022;56:5784–94.PubMedCrossRef Tsilioni I, Natelson B, Theoharides TC. Exosome-associated mitochondrial DNA from patients with myalgic encephalomyelitis/chronic fatigue syndrome stimulates human microglia to release IL-1β. Eur J Neurosci. 2022;56:5784–94.PubMedCrossRef
121.
go back to reference Décary S, Gaboury I, Poirier S, Garcia C, Simpson S, Bull M, et al. Humility and acceptance: Working within our limits with long COVID and myalgic encephalomyelitis/chronic fatigue syndrome. J Orthop Sport Phys. 2021;51:197–200.CrossRef Décary S, Gaboury I, Poirier S, Garcia C, Simpson S, Bull M, et al. Humility and acceptance: Working within our limits with long COVID and myalgic encephalomyelitis/chronic fatigue syndrome. J Orthop Sport Phys. 2021;51:197–200.CrossRef
122.
go back to reference Negro RWD, Turco P, Povero M. Nebivolol: an effective option against long-lasting dyspnoea following COVID-19 pneumonia - a pivotal double-blind, cross-over controlled study. Multidiscip Respir Med. 2022;17:886. Negro RWD, Turco P, Povero M. Nebivolol: an effective option against long-lasting dyspnoea following COVID-19 pneumonia - a pivotal double-blind, cross-over controlled study. Multidiscip Respir Med. 2022;17:886.
123.
go back to reference Pretorius E, Venter C, Laubscher GJ, Kotze MJ, Oladejo SO, Watson LR, et al. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC). Cardiovasc Diabetol. 2022;21:148.PubMedPubMedCentralCrossRef Pretorius E, Venter C, Laubscher GJ, Kotze MJ, Oladejo SO, Watson LR, et al. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC). Cardiovasc Diabetol. 2022;21:148.PubMedPubMedCentralCrossRef
124.
go back to reference Stein E, Heindrich C, Wittke K, Kedor C, Rust R, Freitag H, et al. Efficacy of repeat immunoadsorption in post-COVID ME/CFS patients with elevated Β2-adrenergic receptor autoantibodies: a prospective cohort study. 2024. Stein E, Heindrich C, Wittke K, Kedor C, Rust R, Freitag H, et al. Efficacy of repeat immunoadsorption in post-COVID ME/CFS patients with elevated Β2-adrenergic receptor autoantibodies: a prospective cohort study. 2024.
125.
go back to reference Giszas B, Reuken PA, Katzer K, Kiehntopf M, Schmerler D, Rummler S, et al. Immunoadsorption to treat patients with severe post‐COVID syndrome. Ther Apher Dial. 2023. Giszas B, Reuken PA, Katzer K, Kiehntopf M, Schmerler D, Rummler S, et al. Immunoadsorption to treat patients with severe post‐COVID syndrome. Ther Apher Dial. 2023.
126.
go back to reference Rigo S, Urechie V, Diedrich A, Okamoto LE, Biaggioni I, Shibao CA. Impaired parasympathetic function in long-COVID postural orthostatic tachycardia syndrome – a case-control study. Bioelectron Med. 2023;9:19.PubMedPubMedCentralCrossRef Rigo S, Urechie V, Diedrich A, Okamoto LE, Biaggioni I, Shibao CA. Impaired parasympathetic function in long-COVID postural orthostatic tachycardia syndrome – a case-control study. Bioelectron Med. 2023;9:19.PubMedPubMedCentralCrossRef
127.
go back to reference Glynne P, Tahmasebi N, Gant V, Gupta R. Long COVID following mild SARS-CoV-2 infection: characteristic T cell alterations and response to antihistamines. J Invest Med. 2022;70:61–7.CrossRef Glynne P, Tahmasebi N, Gant V, Gupta R. Long COVID following mild SARS-CoV-2 infection: characteristic T cell alterations and response to antihistamines. J Invest Med. 2022;70:61–7.CrossRef
128.
go back to reference Strayer DR, Young D, Mitchell WM. Effect of disease duration in a randomized Phase III trial of rintatolimod, an immune modulator for myalgic encephalomyelitis/chronic fatigue syndrome. PLoS One. 2020;15: e0240403.PubMedPubMedCentralCrossRef Strayer DR, Young D, Mitchell WM. Effect of disease duration in a randomized Phase III trial of rintatolimod, an immune modulator for myalgic encephalomyelitis/chronic fatigue syndrome. PLoS One. 2020;15: e0240403.PubMedPubMedCentralCrossRef
129.
go back to reference Abani O, Abbas A, Abbas F, Abbas J, Abbas K, Abbas M, et al. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis. Lancet. 2022;400:359–68.CrossRef Abani O, Abbas A, Abbas F, Abbas J, Abbas K, Abbas M, et al. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis. Lancet. 2022;400:359–68.CrossRef
130.
go back to reference Utrero-Rico A, Ruiz-Ruigómez M, Laguna-Goya R, Arrieta-Ortubay E, Chivite-Lacaba M, González-Cuadrado C, et al. A short corticosteroid course reduces symptoms and immunological alterations underlying long-COVID. Biomed. 2021;9:1540. Utrero-Rico A, Ruiz-Ruigómez M, Laguna-Goya R, Arrieta-Ortubay E, Chivite-Lacaba M, González-Cuadrado C, et al. A short corticosteroid course reduces symptoms and immunological alterations underlying long-COVID. Biomed. 2021;9:1540.
131.
go back to reference Castro-Marrero J, Domingo JC, Cordobilla B, Ferrer R, Giralt M, Sanmartín-Sentañes R, et al. Does coenzyme Q10 plus selenium supplementation ameliorate clinical outcomes by modulating oxidative stress and inflammation in individuals with myalgic encephalomyelitis/chronic fatigue syndrome? Antioxid Redox Signal. 2022;36:729–39.PubMedPubMedCentralCrossRef Castro-Marrero J, Domingo JC, Cordobilla B, Ferrer R, Giralt M, Sanmartín-Sentañes R, et al. Does coenzyme Q10 plus selenium supplementation ameliorate clinical outcomes by modulating oxidative stress and inflammation in individuals with myalgic encephalomyelitis/chronic fatigue syndrome? Antioxid Redox Signal. 2022;36:729–39.PubMedPubMedCentralCrossRef
132.
go back to reference Castro-Marrero J, Segundo MJ, Lacasa M, Martinez-Martinez A, Sentañes RS, Alegre-Martin J. Effect of dietary coenzyme Q10 plus NADH supplementation on fatigue perception and health-related quality of life in individuals with myalgic encephalomyelitis/chronic fatigue syndrome: a prospective, randomized, double-blind. Placebo-Controlled Trial Nutrients. 2021;13:2658.PubMed Castro-Marrero J, Segundo MJ, Lacasa M, Martinez-Martinez A, Sentañes RS, Alegre-Martin J. Effect of dietary coenzyme Q10 plus NADH supplementation on fatigue perception and health-related quality of life in individuals with myalgic encephalomyelitis/chronic fatigue syndrome: a prospective, randomized, double-blind. Placebo-Controlled Trial Nutrients. 2021;13:2658.PubMed
133.
go back to reference Rostami S, Alavi SM, Daghagheleh R, Maraghi E, Hosseini SA. A randomized clinical trial investigating the impact of magnesium supplementation on clinical and biochemical measures in COVID-19 patients. Virol J. 2024;21:91.PubMedPubMedCentralCrossRef Rostami S, Alavi SM, Daghagheleh R, Maraghi E, Hosseini SA. A randomized clinical trial investigating the impact of magnesium supplementation on clinical and biochemical measures in COVID-19 patients. Virol J. 2024;21:91.PubMedPubMedCentralCrossRef
Metadata
Title
Towards an understanding of physical activity-induced post-exertional malaise: Insights into microvascular alterations and immunometabolic interactions in post-COVID condition and myalgic encephalomyelitis/chronic fatigue syndrome
Authors
Simon Haunhorst
Diana Dudziak
Carmen Scheibenbogen
Martina Seifert
Franziska Sotzny
Carsten Finke
Uta Behrends
Konrad Aden
Stefan Schreiber
Dirk Brockmann
Paul Burggraf
Wilhelm Bloch
Claudia Ellert
Anuradha Ramoji
Juergen Popp
Philipp Reuken
Martin Walter
Andreas Stallmach
Christian Puta
Publication date
06-09-2024
Publisher
Springer Berlin Heidelberg
Published in
Infection
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-024-02386-8

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more